Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The year's new drugs.

A I Graul1

  • 1Prous Science, Barcelona, Spain.

Drug News & Perspectives
|June 24, 2003
PubMed
Summary

In 2000, 44 new drugs and 2 diagnostics launched. Gastrointestinal drugs led new product introductions, with the United States being the top market.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The year's new drugs and biologics 2020.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

The year's new drugs and biologics 2019.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018.

Drugs of today (Barcelona, Spain : 1998)·2019
Same author

The year's new drugs and biologics 2018: Part I.

Drugs of today (Barcelona, Spain : 1998)·2019
Same author

The year's new drugs & biologics, 2017, part II - News that shaped the industry in 2017.

Drugs of today (Barcelona, Spain : 1998)·2018
Same author

The year's new drugs and biologics 2017: Part I.

Drugs of today (Barcelona, Spain : 1998)·2018

Area of Science:

  • Pharmaceuticals
  • Drug Discovery
  • Market Analysis

Background:

  • The year 2000 marked a significant period for new pharmaceutical and diagnostic product introductions.
  • Tracking new market entrants is crucial for understanding pharmaceutical industry trends.

Purpose of the Study:

  • To analyze the landscape of new chemical entities, biological drugs, and diagnostic agents launched in the year 2000.
  • To identify the leading therapeutic areas and geographical markets for these new product introductions.

Main Methods:

  • Data compilation of new market introductions in 2000.
  • Categorization of products by therapeutic group and market.
  • Analysis of market share for new launches.

Main Results:

  • Forty-four new chemical entities and biological drugs, along with two diagnostic agents, entered the market in 2000.
  • Gastrointestinal drugs represented the most active therapeutic group with seven new launches.
  • The United States was the primary market, accounting for 17 new product launches (37% of the total).

Conclusions:

  • The pharmaceutical market in 2000 saw substantial activity, particularly in gastrointestinal therapeutics.
  • The United States continued to be a dominant market for new drug and diagnostic introductions.

Related Experiment Videos